[1] WIJNANDS A M, DE JONG M E, LUTGENS M W M D, et al. Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis[J].Gastroenterology,2021, 160(5):1584-1598. [2] CAO B, MIN L, ZHU S T, et al. Long-term oncological outcomes of local excision versus radical resection for early colorectal cancer in young patients without preoperative chemoradiotherapy: a population-based propensity matching study[J].Cancer Med,2018,7(6):2415-2422. [3] LOU F F, SUN Z R, HUANG N S, et al. Epidural combined with general anesthesia versus general anesthesia alone in patients undergoing free flap breast reconstruction[J].Plast Reconstr Surg,2016, 137(3):502-509. [4] EISENHAUER E A, THERASSE P, BOGAERTS J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J].Eur Cancer,2009, 45(2):211-247. [5] 国家卫生计生委医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志, 2018, 42(4):241-258. [6] 姚宏伟, 吴鸿伟, 刘荫华. 美国癌症联合委员会第八版结直肠癌分期更新及其“预后和预测”评价体系[J].中华胃肠外科杂志, 2017, 20(1):4. [7] SALEH R, TAHA R Z, TOOR S M, et al. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer [J].Cancer Immunol Immunother,2020, 69(10):1989-1999. [8] 王强. 结直肠癌肝转移术后采用扶正固本汤治疗的临床效果[J].中国实用医药,2021,16(28):164-166. [9] 王东轶. 穴位注射治疗肠癌化疗后脾肾阳虚型白细胞减少症的临床研究[D].昆明:云南中医学院,2017. [10] 丁宁. 祛邪胶囊治疗结直肠癌的机制研究及用药方式初探[D].北京:中国中医科学院,2014. [11] 李辉. 扶正化瘀散结汤联合平消片对直肠癌术后患者体液免疫功能及预后的影响[J].光明中医,2022,37(17):3150-3152. [12] 李振前,杨梦春,刘戎惠. 扶正消癌汤合四君子汤联合卡培他滨治疗晚期结直肠癌临床研究[J].陕西中医,2022,43(8):1037-1040.
2024, Vol. 41 
